These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 32739305)

  • 21. Fractional Flow Reserve and Cardiac Events in Coronary Artery Disease: Data From a Prospective IRIS-FFR Registry (Interventional Cardiology Research Incooperation Society Fractional Flow Reserve).
    Ahn JM; Park DW; Shin ES; Koo BK; Nam CW; Doh JH; Kim JH; Chae IH; Yoon JH; Her SH; Seung KB; Chung WY; Yoo SY; Lee JB; Choi SW; Park K; Hong TJ; Lee SY; Han M; Lee PH; Kang SJ; Lee SW; Kim YH; Lee CW; Park SW; Park SJ;
    Circulation; 2017 Jun; 135(23):2241-2251. PubMed ID: 28356440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of Major Adverse Cardiac Events Between Instantaneous Wave-Free Ratio and Fractional Flow Reserve-Guided Strategy in Patients With or Without Type 2 Diabetes: A Secondary Analysis of a Randomized Clinical Trial.
    ; Lee JM; Choi KH; Koo BK; Dehbi HM; Doh JH; Nam CW; Shin ES; Cook CM; Al-Lamee R; Petraco R; Sen S; Malik IS; Nijjer SS; Mejía-Rentería H; Alegria-Barrero E; Alghamdi A; Altman J; Baptista SB; Bhindi R; Bojara W; Brugaletta S; Silva PC; Di Mario C; Erglis A; Gerber RT; Going O; Härle T; Hellig F; Indolfi C; Janssens L; Jeremias A; Kharbanda RK; Khashaba A; Kikuta Y; Krackhardt F; Laine M; Lehman SJ; Matsuo H; Meuwissen M; Niccoli G; Piek JJ; Ribichini F; Samady H; Sapontis J; Seto AH; Sezer M; Sharp ASP; Singh J; Takashima H; Talwar S; Tanaka N; Tang K; Van Belle E; van Royen N; Vinhas H; Vrints CJ; Walters D; Yokoi H; Samuels B; Buller C; Patel MR; Serruys P; Escaned J; Davies JE
    JAMA Cardiol; 2019 Sep; 4(9):857-864. PubMed ID: 31314045
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coronary computed tomography angiography derived fractional flow reserve and risk of recurrent angina: A 3-year follow-up study.
    Madsen KT; Nørgaard BL; Øvrehus KA; Jensen JM; Parner E; Grove EL; Mortensen MB; Fairbairn TA; Nieman K; Patel MR; Rogers C; Mullen S; Mickley H; Thomsen KK; Bøtker HE; Leipsic J; Sand NPR
    J Cardiovasc Comput Tomogr; 2024; 18(3):243-250. PubMed ID: 38246785
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic and Prognostic Implications of Coronary Flow Capacity: A Comprehensive Cross-Modality Physiological Concept in Ischemic Heart Disease.
    van de Hoef TP; Echavarría-Pinto M; van Lavieren MA; Meuwissen M; Serruys PW; Tijssen JG; Pocock SJ; Escaned J; Piek JJ
    JACC Cardiovasc Interv; 2015 Nov; 8(13):1670-80. PubMed ID: 26585617
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fractional Flow Reserve-Guided Complete Revascularization Improves the Prognosis in Patients With ST-Segment-Elevation Myocardial Infarction and Severe Nonculprit Disease: A DANAMI 3-PRIMULTI Substudy (Primary PCI in Patients With ST-Elevation Myocardial Infarction and Multivessel Disease: Treatment of Culprit Lesion Only or Complete Revascularization).
    Lønborg J; Engstrøm T; Kelbæk H; Helqvist S; Kløvgaard L; Holmvang L; Pedersen F; Jørgensen E; Saunamäki K; Clemmensen P; De Backer O; Ravkilde J; Tilsted HH; Villadsen AB; Aarøe J; Jensen SE; Raungaard B; Køber L; Høfsten DE;
    Circ Cardiovasc Interv; 2017 Apr; 10(4):. PubMed ID: 28404623
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of malondialdehyde-modified low-density lipoprotein on clinical outcomes after fractional flow reserve-guided deferral of revascularization.
    Yokoi M; Ito T; Fujita H; Sugiura T; Seo Y; Ohte N
    Heart Vessels; 2021 May; 36(5):605-614. PubMed ID: 33219835
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Invasive FFR and Noninvasive CFR in the Evaluation of Ischemia: What Is the Future?
    Johnson NP; Gould KL; Di Carli MF; Taqueti VR
    J Am Coll Cardiol; 2016 Jun; 67(23):2772-2788. PubMed ID: 27282899
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of Anatomical and Clinical Characteristics on Long-Term Prognosis of FFR-Guided Deferred Coronary Lesions.
    Cho YK; Hwang J; Lee CH; Kim IC; Park HS; Yoon HJ; Kim H; Han SW; Hur SH; Kim KB; Kim JY; Doh JH; Shin ES; Koo BK; Nam CW
    JACC Cardiovasc Interv; 2020 Aug; 13(16):1907-1916. PubMed ID: 32819479
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcomes after revascularisation with everolimus- and sirolimus-eluting stents in patients with acute coronary syndromes and stable angina pectoris: a substudy of the SORT OUT IV trial.
    Antonsen L; Thayssen P; Hansen HS; Maeng M; Tilsted HH; Bøtker HE; Ravkilde J; Madsen M; Sørensen HT; Thuesen L; Lassen JF; Jensen LO
    EuroIntervention; 2014 Jun; 10(2):212-23. PubMed ID: 23838425
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Meta-Analysis of Death and Myocardial Infarction in the DEFINE-FLAIR and iFR-SWEDEHEART Trials.
    Berry C; McClure JD; Oldroyd KG
    Circulation; 2017 Dec; 136(24):2389-2391. PubMed ID: 28972006
    [No Abstract]   [Full Text] [Related]  

  • 31. Instantaneous wave free ratio vs. fractional flow reserve and 5-year mortality: iFR SWEDEHEART and DEFINE FLAIR.
    Eftekhari A; Holck EN; Westra J; Olsen NT; Bruun NH; Jensen LO; Engstrøm T; Christiansen EH
    Eur Heart J; 2023 Nov; 44(41):4376-4384. PubMed ID: 37634144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical Outcomes of Deferred Revascularisation Using Fractional Flow Reserve in Diabetic Patients.
    Alkhalil M; McCune C; McClenaghan L; Mailey J; Collins P; Kearney A; Todd M; McKavanagh P
    Cardiovasc Revasc Med; 2020 Jul; 21(7):897-902. PubMed ID: 31883978
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reclassification of Treatment Strategy With Instantaneous Wave-Free Ratio and Fractional Flow Reserve: A Substudy From the iFR-SWEDEHEART Trial.
    Andell P; Berntorp K; Christiansen EH; Gudmundsdottir IJ; Sandhall L; Venetsanos D; Erlinge D; Fröbert O; Koul S; Reitan C; Götberg M
    JACC Cardiovasc Interv; 2018 Oct; 11(20):2084-2094. PubMed ID: 30336812
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-fibroatheroma lesion phenotype and long-term clinical outcomes: a substudy analysis from the PROSPECT study.
    Dohi T; Mintz GS; McPherson JA; de Bruyne B; Farhat NZ; Lansky AJ; Mehran R; Weisz G; Xu K; Stone GW; Maehara A
    JACC Cardiovasc Imaging; 2013 Aug; 6(8):908-16. PubMed ID: 23850249
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical Outcomes in Patients with Deferred Coronary Lesions according to Disease Severity Assessed by Fractional Flow Reserve.
    Won KB; Nam CW; Cho YK; Yoon HJ; Park HS; Kim H; Han S; Hur SH; Kim YN; Park SH; Han JK; Koo BK; Kim HS; Doh JH; Lee SY; Yang HM; Lim HS; Yoon MH; Tahk SJ; Kim KB
    J Korean Med Sci; 2016 Dec; 31(12):1929-1936. PubMed ID: 27822931
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcomes With Deferred Versus Performed Revascularization of Coronary Lesions With Gray-Zone Fractional Flow Reserve Values.
    Megaly M; Khalil C; Saad M; Xenogiannis I; Omer M; Anantha Narayanan M; Pershad A; Garcia S; Seto AH; Burke MN; Brilakis ES
    Circ Cardiovasc Interv; 2019 Dec; 12(12):e008315. PubMed ID: 31752518
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognosis of deferred non-culprit lesions according to fractional flow reserve in patients with acute coronary syndrome.
    Lee JM; Choi KH; Koo BK; Shin ES; Nam CW; Doh JH; Hwang D; Park J; Zhang J; Lim HS; Yoon MH; Tahk SJ
    EuroIntervention; 2017 Oct; 13(9):e1112-e1119. PubMed ID: 28691907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of medical treatment and coronary revascularization in patients with moderate coronary lesions and borderline fractional flow reserve measurements.
    Courtis J; Rodés-Cabau J; Larose E; Déry JP; Nguyen CM; Proulx G; Gleeton O; Roy L; Barbeau G; Noël B; DeLarochellière R; Bertrand OF
    Catheter Cardiovasc Interv; 2008 Mar; 71(4):541-8. PubMed ID: 18307236
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Five-Year Outcomes After Fractional Flow Reserve-Based Deferral of Revascularization in Chronic Coronary Syndrome: Final Results From the J-CONFIRM Registry.
    Kuramitsu S; Matsuo H; Shinozaki T; Horie K; Takashima H; Terai H; Kikuta Y; Ishihara T; Saigusa T; Sakamoto T; Suematsu N; Shiono Y; Asano T; Tsujita K; Masamura K; Doijiri T; Toyota F; Ogita M; Kurita T; Matsuo A; Harada K; Yaginuma K; Sonoda S; Yokoi H; Tanaka N;
    Circ Cardiovasc Interv; 2022 Feb; 15(2):e011387. PubMed ID: 35130711
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thrombotic Risk and Cardiovascular Events in Patients With Revascularization Deferral After Fractional Flow Reserve Assessment.
    Shiono Y; Kuramitsu S; Matsuo H; Horie K; Takashima H; Terai H; Kikuta Y; Ishihara T; Saigusa T; Sakamoto T; Suematsu N; Asano T; Tsujita K; Masamura K; Doijiri T; Toyota F; Ogita M; Kurita T; Matsuo A; Harada K; Yaginuma K; Sonoda S; Tanaka A; Yokoi H; Tanaka N;
    JACC Cardiovasc Interv; 2022 Feb; 15(4):427-439. PubMed ID: 35210049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.